These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31771905)

  • 61. Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms.
    Mizuno Y; Kudo A; Akashi T; Akahoshi K; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tanaka S; Tateishi U; Tanabe M
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1155-1163. PubMed ID: 29602973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Radiofrequency ablation of pancreatic neuroendocrine tumor].
    Hlavsa J; Procházka V; Kala Z; Man M; Andrasina T; Cíhalová M; Válek V; Crha M; Svobodová I; Urbanová L
    Klin Onkol; 2011; 24(3):209-15. PubMed ID: 21717790
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.
    Vashist YK; Uzunoglu G; Deutsch L; Kalinin V; Zehler O; Alzadjali A; Kutup A; Izbicki JR; Yekebas EF
    J Surg Res; 2011 Apr; 166(2):e121-7. PubMed ID: 21236443
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior.
    Díaz Del Arco C; Esteban López-Jamar JM; Ortega Medina L; Díaz Pérez JÁ; Fernández Aceñero MJ
    Diagn Cytopathol; 2017 Jan; 45(1):29-35. PubMed ID: 27863178
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs).
    Vernieri C; Pusceddu S; Fucà G; Indelicato P; Centonze G; Castagnoli L; Ferrari E; Ajazi A; Pupa S; Casola S; Foiani M; Mazzaferro V; Pruneri G; Milione M; de Braud F
    Int J Cancer; 2019 Apr; 144(7):1704-1712. PubMed ID: 30520016
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
    Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F
    Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pancreatic neuroendocrine tumors: role of novel agents. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2011 Mar; 12(2):117-9. PubMed ID: 21386634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Standard pre- and postoperative determination of chromogranin a in resectable non-functioning pancreatic neuroendocrine tumors--diagnostic accuracy: NF-pNET and low tumor burden.
    Jilesen AP; Busch OR; van Gulik TM; Gouma DJ; Nieveen van Dijkum EJ
    Dig Surg; 2014; 31(6):407-14. PubMed ID: 25572908
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.
    Tomimaru Y; Eguchi H; Tatsumi M; Kim T; Hama N; Wada H; Kawamoto K; Kobayashi S; Morii E; Mori M; Doki Y; Nagano H
    Surgery; 2015 Feb; 157(2):269-76. PubMed ID: 25311263
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Outcome of surgery for pancreatic neuroendocrine neoplasms.
    Fischer L; Bergmann F; Schimmack S; Hinz U; Prieß S; Müller-Stich BP; Werner J; Hackert T; Büchler MW
    Br J Surg; 2014 Oct; 101(11):1405-12. PubMed ID: 25132004
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Imbalanced expression of Vcan mRNA splice form proteins alters heart morphology and cellular protein profiles.
    Burns TA; Dours-Zimmermann MT; Zimmermann DR; Krug EL; Comte-Walters S; Reyes L; Davis MA; Schey KL; Schwacke JH; Kern CB; Mjaatvedt CH
    PLoS One; 2014; 9(2):e89133. PubMed ID: 24586547
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R; Burk KS; Parakh A; Sahani DV
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor From Other Neoplastic Solid Pancreatic Lesions During Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Krishna SG; Bhattacharya A; Li F; Ross WA; Ladha H; Porter K; Atiq M; Bhutani MS; Lee JH
    Pancreas; 2016 Mar; 45(3):394-400. PubMed ID: 26418912
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors.
    Song KB; Kim SC; Kim JH; Seo DW; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
    Pancreas; 2016 Feb; 45(2):187-92. PubMed ID: 26474434
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors.
    Cros J; Hentic O; Rebours V; Zappa M; Gille N; Theou-Anton N; Vernerey D; Maire F; Lévy P; Bedossa P; Paradis V; Hammel P; Ruszniewski P; Couvelard A
    Endocr Relat Cancer; 2016 Aug; 23(8):625-33. PubMed ID: 27353036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Life expectancy in pancreatic neuroendocrine cancer.
    Brooks JC; Shavelle RM; Vavra-Musser KN
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):88-97. PubMed ID: 30220478
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters.
    Faggiano A; Modica R; Lo Calzo F; Camera L; Napolitano V; Altieri B; de Cicco F; Bottiglieri F; Sesti F; Badalamenti G; Isidori AM; Colao A
    J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31586182
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Versican expression in tumor epithelial cells is correlated with a good prognosis in gastric cancer.
    Kim NS; Lee HH; Jung CK; Jeon HM
    Anticancer Res; 2014 Oct; 34(10):5613-9. PubMed ID: 25275064
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
    Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
    BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.